Inselspital, Universitätsspital Bern

Environmental triggers in IBD: a review of progress and evidence (2018) Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath M, Ali RAR, Vavricka SR, Fiocchi C Journal article Somatostatin receptor PET/CT (SSTR-PET/CT) (2018) Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, et al. Journal article International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, et al. Journal article Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Mueller TA, et al. Journal article Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial (2017) Walter I, Schulz U, Vogelhuber M, Wiedmann K, Endlicher E, Klebl F, Andreesen R, et al. Journal article Diagnostic value of contrast-enhanced mag-netic resonance angiography in large-vessel vasculitis (2017) Adler S, Sprecher M, Wermelinger F, Klink T, Bonel HM, Villiger PM Journal article ISLES 2015 - A public evaluation benchmark for ischemic stroke lesion segmentation from multispectral MRI (2017) Maier O, Menze BH, Von Der Gablentz J, Hani L, Heinrich MP, Liebrand M, Winzeck S, et al. Journal article Association of adaptive and maladaptive narcissism with personal burnout: Findings from a cross-sectional study (2017) Von Känel R, Herr RM, Van Vianen AEM, Schmidt B Journal article Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial (2017) Polgar C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article